News
UCB's ongoing commitment to advancing research for people living with epilepsiesData include an open-label extension study describing the long-term safety of FINTEPLA®â–¼ (fenfluramine)[1] and global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback